Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Self-interest before Shareholder interest

This says it all:

Did ANY shareholder believe the BOD could override that particular vote?

And why take so long to tell us?

Q: What is the status of the majority voting resolution approved at the last stockholders' meeting?

A: As you are aware, last year at our 2011 Annual Meeting of Stockholders, our stockholders voted on a proposal (Proposal No. 3) which requested that our Board of Directors initiate a process to amend our governance documents to provide for majority voting with respect to the annual election of our Board of Directors. While this proposal was approved by the requisite vote at our 2011 Annual Meeting of Stockholders, the proposal was non-binding upon our Board of Directors and therefore its implementation is at the discretion of our Board of Directors. After careful consideration, the Board of Directors has decided to retain the plurality voting standard and not implement the proposal. The principal factors upon which the Board made its decision include the fact that a substantial majority of public companies still use the plurality standard due to the increased likelihood of a failed election or the potential that stockholders would not elect a director that is needed to satisfy a regulatory or experience requirement. We expect the topic of stockholder proposals to be addressed during the upcoming stockholder meeting.

Share
New Message
Please login to post a reply